# EDGAR Filing Document

**Accession Number:** 0000019617
**File Stem:** 0001225208-26-005409
**Filing Date:** 2026-5
**Character Count:** 9864
**Document Hash:** 9dfd043e9adc3258eb399fb959b014e3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001225208-26-005409.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001225208-26-005409

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260514

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Petno Douglas B
- **CENTRAL INDEX KEY:** 0001539649

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05805
- **FILM NUMBER:** 26990247

**MAIL ADDRESS:**
- **STREET 1:** JPMORGAN CHASE & CO.
- **STREET 2:** 270 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMORGAN CHASE & CO
- **CENTRAL INDEX KEY:** 0000019617
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 132624428
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 270 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 2122706000

**MAIL ADDRESS:**
- **STREET 1:** 270 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J P MORGAN CHASE & CO
- **DATE OF NAME CHANGE:** 20010102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHASE MANHATTAN CORP /DE/
- **DATE OF NAME CHANGE:** 19960402

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEMICAL BANKING CORP
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

```

JPMorgan Chase & Co.
Power of Attorney
For Preparing, Signing and Filing Certain Reports with the SEC

	KNOW ALL BY THESE PRESENTS, that the undersigned in his or her capacity as
an officer or director of JPMorgan Chase & Co. ("JPMC") hereby constitutes and
appoints each of Stacey Friedman, John H. Tribolati, Reid R. Broda,
Carin S. Reddish, and Denise G. Connors, signing singly, his/her true and lawful

attorney-in-fact to:

(1)	prepare and execute for and on behalf of the undersigned in connection with
transactions in JPMC securities (a) any and all forms of report, including
amendments to such reports, required to be made pursuant to Section 16(a) of the
Securities Exchange Act of 1934 (the "Exchange Act") and related rules of the
Securities and Exchange Commission ("SEC") and (b) any documents or reports
which may be required under SEC Rule 144 to permit the undersigned to sell JPMC
common stock without registration under the Securities Act of 1933 (the "1933
Act") in reliance on Rule 144 as amended from time to time;

(2)	apply for, if required, and administer Edgar codes on behalf of the
undersigned to enable electronic filings with the SEC;

(3)	do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable for the preparation and timely filing of any such
reports, documents and reports with the SEC, any United States stock exchange,
and any other authority; and

(4)	take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform each and every act and thing whatsoever requisite,
necessary and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or his or her
substitute or substitutes, shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers hereby granted. The undersigned
acknowledges that none of the foregoing attorneys-in-fact in serving in such
capacity at the request of the undersigned is assuming any of the undersigned's
responsibilities to comply with either the Exchange Act or the 1933 Act.

	The undersigned attests and agrees that the use of an electronic signature
in any authentication document that includes the undersigned's typed,
conformed signature, or that includes the typed, conformed signature
of any attorney-in-fact of the undersigned, and that is filled with or
furnished to the SEC by or on behalf of the undersigned, JPMC of any of
its affiliates, constitutes the legal equivalent of the undersigned's, manual
signature for purposes of authenticating the undersigned's signature to
any filing or submission for which it is provided.

		IN WITNESS WHEREOF, the undersigned has executed this Power of
Attorney as of May 4, 2026.

						/s/  Douglas B. Petno
						     Douglas B. Petno

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Petno Douglas B<br><sub>(Last) (First) (Middle)</sub><br>270 PARK AVENUE<br><sub>(Street)</sub><br>NEW YORK, NY 10017-2014<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-05-14 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Co-CEO CIB_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>JPMORGAN CHASE & CO [ JPM ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-05-14 |  | G |  | 135027 | D | $0 | 230278<sup>(1)</sup> | D |  |
| Common Stock | 2026-05-15 |  | S |  | 5659 | D | $300.0500 | 224619 | D |  |
| Common Stock | 2026-05-14 |  | G |  | 135027 | A | $0 | 135027 | I | By Spouse |
| Common Stock |  |  |  |  |  |  |  | 70457 | I | By Family Trusts |
| Common Stock |  |  |  |  |  |  |  | 16502<sup>(1)</sup> | I | By GRAT |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Balance reflects 16,502 shares transferred from the Grantor to a Grantor Retained Annuity Trust ("GRAT") on May 14, 2026. This transaction is exempt from Section 16(b) pursuant to Rule 16a-13.

**Remarks:**
poapetno.txt

**Signature:** /s/ Denise G. Connors under POA  
**Date:** 2026-05-15

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**